The heptavalent conjugate pneumococcal vaccine and its implications for managed care--clinical overview and roundtable discussions.
Alexander
P G
PG
Chartrand
S A
SA
Davies
T J
TJ
Gaines
B M
BM
Oster
G
G
Shurin
P
P
Tamsky
L
L
Thornton
D K
DK
Wittert
W
W
D002656:Child Day Care Centers / Q000592:standards; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D004502:Education, Medical, Continuing; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D019458:Insurance Coverage; D008329:Managed Care Programs / Q000191:economics* / Q000592:standards*; D008484:Medicaid; D022401:Meningococcal Vaccines / Q000008:administration & dosage* / Q000191:economics*; D011008:Pneumococcal Infections / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage* / Q000191:economics*; D017410:Practice Guidelines as Topic; D014481:United States; D014611:Vaccination / Q000191:economics / Q000592:standards
D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines